Real-time · AI · Cross-signal

Full Life Technologies just raised. Here's exactly what to do next.

Who to reach, what to say, and why now — on Full Life Technologies, plus every funding round, exec hire, and M&A move that follows, each with verified, ICP-ranked contacts.

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Get the full Deep Dive on Full Life Technologies — free.

We'll email your report. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Everyone else gives you a piece

✕Crunchbase & PitchBook list the company — No person, no timing, no opener.

✕ZoomInfo & Apollo sell you a contact — No trigger, no reason to reach out now.

✕LinkedIn Sales Navigator shows you people — No real-time signal, no opener.

✕Clay enriches lists you built — No live signal of its own, no who or when.

✕ChatGPT & gen-AI tools answer on a delay — No live data, no verified contact.

Who to contactWhat to sayWhen to reach outWhy now

Only Fundz delivers all four.

Full-Life Technologies raised US$150M in financing, led by Vivo Capital, including US$110M in Series D and US$40M in debt. The funds aim to expand operations and R&D efforts.

PRIVATEMay 19, 2026•21 days ago

Amount Raised

$150 Million

Round Type

series d

ShanghaiBiotechnologyCommunity And LifestyleScience And Engineering

Investors

Tsg CapitalSky9 CapitalPlaisanceYunionJunson CapitalHsgChengwei CapitalSk Biopharmaceuticals Co., Ltd.Vivo Capital

Description

Full-Life Technologies, a Suzhou, China-based radiotherapeutics company, raised US$150M in financing. The round consisted of approximately US$110M in Series D equity and US$40M in debt financing. Led by Vivo Capital, the investors included SK Biopharmaceuticals and others. The company intends to use the funds to expand operations and its R&D efforts.

Company Information

Company

Full Life Technologies

Location

Shanghai, Shanghai, China

About

Full-Life Technologies Limited ("Full-Life") is a fully integrated global radiotherapeutics company headquartered in Shanghai with operations in Europe. We seek to own the entire value chain for radio-ligand production, research, development & commercialization in order to deliver clinical impact for patients. Our core platform seeks to attack the two core issues that exist in radiopharmaceuticals today including innovative translational & biology research platform targeting the radiopharma treatments of tomorrow. We are comprised of a team of fast-moving entrepreneurs & scientists with demonstrated track record in life science company building as well as radioisotope research and clinical development. From Half-Life to Full-Life. Contact:Email: pr@t-full.comWebsite: https://www.full-life.com View original content:https://www.prnewswire.com/news-releases/full-life-technologies-completes-37-million-usd-series-a-financing-to-accelerate-development-of-its-radiopharmaceutical-pipeline-and-radiotechnology-production-platform-301553416.html

Related People

Suggested for you

1 contact

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Full Life Technologies's next move

Learn about Strategic plan

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Watching Full Life Technologies? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demo Choose your plan